- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 12 x CU: COPPER (II) ION(Non-covalent)
- 18 x D10: DECANE(Non-functional Binders)(Non-covalent)
D10.3: 3 residues within 4Å:- Chain A: V.248
- Ligands: PLC.4, PLC.65
Ligand excluded by PLIPD10.6: 7 residues within 4Å:- Chain B: F.229, M.230, F.233
- Ligands: D10.7, D10.9, D10.34, P1O.37
Ligand excluded by PLIPD10.7: 7 residues within 4Å:- Chain B: M.230, F.233, I.234, W.237
- Ligands: D10.6, D10.8, D10.9
Ligand excluded by PLIPD10.8: 7 residues within 4Å:- Chain B: W.237, F.238, R.242
- Ligands: D10.7, P1O.10, D10.41, D10.44
Ligand excluded by PLIPD10.9: 5 residues within 4Å:- Ligands: D10.6, D10.7, D10.34, D10.35, D10.44
Ligand excluded by PLIPD10.16: 5 residues within 4Å:- Ligands: HXG.15, PLC.23, D10.51, HXG.62, D10.63
Ligand excluded by PLIPD10.26: 3 residues within 4Å:- Chain D: V.248
- Ligands: PLC.18, PLC.39
Ligand excluded by PLIPD10.29: 3 residues within 4Å:- Chain E: V.248
- Ligands: PLC.30, PLC.53
Ligand excluded by PLIPD10.32: 7 residues within 4Å:- Chain F: F.229, M.230, F.233
- Ligands: D10.33, D10.35, P1O.38, D10.43
Ligand excluded by PLIPD10.33: 7 residues within 4Å:- Chain F: M.230, F.233, I.234, W.237
- Ligands: D10.32, D10.34, D10.35
Ligand excluded by PLIPD10.34: 7 residues within 4Å:- Chain F: W.237, F.238, R.242
- Ligands: D10.6, D10.9, D10.33, P1O.37
Ligand excluded by PLIPD10.35: 5 residues within 4Å:- Ligands: D10.9, D10.32, D10.33, D10.43, D10.44
Ligand excluded by PLIPD10.41: 7 residues within 4Å:- Chain G: F.229, M.230, F.233
- Ligands: D10.8, P1O.10, D10.42, D10.44
Ligand excluded by PLIPD10.42: 7 residues within 4Å:- Chain G: M.230, F.233, I.234, W.237
- Ligands: D10.41, D10.43, D10.44
Ligand excluded by PLIPD10.43: 7 residues within 4Å:- Chain G: W.237, F.238, R.242
- Ligands: D10.32, D10.35, P1O.38, D10.42
Ligand excluded by PLIPD10.44: 5 residues within 4Å:- Ligands: D10.8, D10.9, D10.35, D10.41, D10.42
Ligand excluded by PLIPD10.51: 5 residues within 4Å:- Ligands: HXG.15, D10.16, PLC.45, HXG.50, D10.63
Ligand excluded by PLIPD10.63: 5 residues within 4Å:- Ligands: D10.16, PLC.36, HXG.50, D10.51, HXG.62
Ligand excluded by PLIP- 18 x PLC: DIUNDECYL PHOSPHATIDYL CHOLINE(Non-covalent)
PLC.4: 21 residues within 4Å:- Chain A: I.244, V.248, M.251, N.255, T.261
- Chain B: R.57, I.130, G.151, L.154, I.155, Y.157, P.158, W.161, A.213, P.214, A.217, F.218
- Chain E: Y.381
- Ligands: D10.3, PLC.64, PLC.65
Ligand excluded by PLIPPLC.14: 20 residues within 4Å:- Chain A: T.80
- Chain C: L.197, W.200, F.204, W.205, F.206, M.207, P.214, G.218
- Chain G: L.59, T.62, V.63, I.66, V.67, T.204, F.219, M.223, I.227
- Ligands: HXG.15, PLC.45
Ligand excluded by PLIPPLC.17: 28 residues within 4Å:- Chain C: S.51, F.52, F.56, E.57, M.61, L.64, Y.65, I.68, V.69, I.72, T.138, D.139, F.140, Y.149, L.192, P.193, V.195, G.196, E.199
- Chain G: M.150, G.209, K.210, D.211, P.214, V.215, F.218
- Ligands: PLC.18, PLC.39
Ligand excluded by PLIPPLC.18: 11 residues within 4Å:- Chain C: I.68, I.72, F.140, Y.149, P.153, L.192
- Chain G: P.214, F.218
- Ligands: PLC.17, D10.26, PLC.39
Ligand excluded by PLIPPLC.20: 17 residues within 4Å:- Chain C: V.31, F.32, W.35, W.38, Y.39, Y.43, Y.59, F.63, T.66, E.67, L.70, E.71, T.74, L.150, I.154, I.157
- Ligands: P1O.21
Ligand excluded by PLIPPLC.23: 16 residues within 4Å:- Chain B: H.40, T.44, V.63, V.67, M.199, M.223
- Chain C: L.210, V.212, Y.217, V.220, I.221, W.224
- Ligands: HXG.15, D10.16, PLC.61, HXG.62
Ligand excluded by PLIPPLC.30: 21 residues within 4Å:- Chain D: Y.381
- Chain E: I.244, V.248, M.251, N.255, T.261
- Chain F: R.57, I.130, G.151, L.154, I.155, Y.157, P.158, W.161, A.213, P.214, A.217, F.218
- Ligands: D10.29, PLC.52, PLC.53
Ligand excluded by PLIPPLC.36: 13 residues within 4Å:- Chain F: T.44, V.63, V.67, M.199, M.223
- Chain I: V.212, Y.217, V.220, W.224
- Ligands: PLC.49, HXG.50, HXG.62, D10.63
Ligand excluded by PLIPPLC.39: 21 residues within 4Å:- Chain A: Y.381
- Chain D: I.244, V.248, M.251, N.255, T.261
- Chain G: R.57, I.130, G.151, L.154, I.155, Y.157, P.158, W.161, A.213, P.214, A.217, F.218
- Ligands: PLC.17, PLC.18, D10.26
Ligand excluded by PLIPPLC.45: 14 residues within 4Å:- Chain D: Q.145
- Chain G: T.44, V.63, V.67, M.199, M.223
- Chain H: V.212, Y.217, V.220, W.224
- Ligands: PLC.14, HXG.15, HXG.50, D10.51
Ligand excluded by PLIPPLC.49: 21 residues within 4Å:- Chain D: T.80
- Chain F: L.59, T.62, V.63, I.66, V.67, T.204, F.219, M.223, I.227
- Chain H: L.197, W.200, F.204, W.205, F.206, M.207, P.214, Y.217, G.218
- Ligands: PLC.36, HXG.50
Ligand excluded by PLIPPLC.52: 28 residues within 4Å:- Chain F: M.150, G.209, K.210, D.211, P.214, V.215, F.218
- Chain H: S.51, F.52, F.56, E.57, M.61, L.64, Y.65, I.68, V.69, I.72, T.138, D.139, F.140, Y.149, L.192, P.193, V.195, G.196, E.199
- Ligands: PLC.30, PLC.53
Ligand excluded by PLIPPLC.53: 11 residues within 4Å:- Chain F: P.214, F.218
- Chain H: I.68, I.72, F.140, Y.149, P.153, L.192
- Ligands: D10.29, PLC.30, PLC.52
Ligand excluded by PLIPPLC.55: 17 residues within 4Å:- Chain H: V.31, F.32, W.35, W.38, Y.39, Y.43, Y.59, F.63, T.66, E.67, L.70, E.71, T.74, L.150, I.154, I.157
- Ligands: P1O.56
Ligand excluded by PLIPPLC.61: 20 residues within 4Å:- Chain B: L.59, T.62, V.63, I.66, V.67, T.204, F.219, M.223, I.227
- Chain E: T.80
- Chain I: L.197, W.200, F.204, W.205, F.206, M.207, P.214, G.218
- Ligands: PLC.23, HXG.62
Ligand excluded by PLIPPLC.64: 28 residues within 4Å:- Chain B: M.150, G.209, K.210, D.211, P.214, V.215, F.218
- Chain I: S.51, F.52, F.56, E.57, M.61, L.64, Y.65, I.68, V.69, I.72, T.138, D.139, F.140, Y.149, L.192, P.193, V.195, G.196, E.199
- Ligands: PLC.4, PLC.65
Ligand excluded by PLIPPLC.65: 11 residues within 4Å:- Chain B: P.214, F.218
- Chain I: I.68, I.72, F.140, Y.149, P.153, L.192
- Ligands: D10.3, PLC.4, PLC.64
Ligand excluded by PLIPPLC.67: 17 residues within 4Å:- Chain I: V.31, F.32, W.35, W.38, Y.39, Y.43, Y.59, F.63, T.66, E.67, L.70, E.71, T.74, L.150, I.154, I.157
- Ligands: P1O.68
Ligand excluded by PLIP- 12 x P1O: 1,2-DIDECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
P1O.5: 11 residues within 4Å:- Chain A: R.233
- Chain B: V.134, L.137, S.138, G.139, S.140, F.143
- Chain I: W.79, F.160, I.164
- Ligands: P1O.69
5 PLIP interactions:2 interactions with chain B, 2 interactions with chain I, 1 interactions with chain F- Hydrophobic interactions: B:F.143, B:F.143, I:F.160, I:F.160
- Hydrogen bonds: F:T.247
P1O.10: 19 residues within 4Å:- Chain B: W.237, R.242, F.243, L.244, S.246, T.247
- Chain C: L.179, L.182, V.183, V.186, G.187, L.225
- Chain G: L.142, F.229, H.232, F.233, R.236
- Ligands: D10.8, D10.41
10 PLIP interactions:6 interactions with chain G, 1 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: G:L.142, G:F.229, G:F.229, G:F.233, C:L.182, B:W.237, B:W.237
- Salt bridges: G:H.232, G:R.236, B:R.242
P1O.21: 21 residues within 4Å:- Chain C: K.19, W.21, F.24, A.25, I.28, Y.29, T.74, L.78, Y.81, L.82, R.101, T.104, V.107, W.108, A.111, I.154, I.157, T.158, Y.165, R.169
- Ligands: PLC.20
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:W.21, C:W.21, C:F.24, C:W.108
- Salt bridges: C:K.19, C:K.19
P1O.22: 19 residues within 4Å:- Chain B: T.247
- Chain C: S.76, W.79, G.80, W.83, F.160, F.163, I.164, K.167, I.177, L.182, V.186, F.189
- Chain G: S.140, L.142, F.143, I.146, V.147
- Ligands: P1O.40
6 PLIP interactions:5 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:W.83, C:W.83, C:F.160, C:L.182, B:T.247
- Salt bridges: C:K.167
P1O.31: 11 residues within 4Å:- Chain E: R.233
- Chain F: V.134, L.137, S.138, G.139, S.140, F.143
- Chain H: W.79, F.160, I.164
- Ligands: P1O.57
4 PLIP interactions:2 interactions with chain H, 2 interactions with chain F- Hydrophobic interactions: H:F.160, H:F.160, F:F.143, F:F.143
P1O.37: 20 residues within 4Å:- Chain B: L.142, F.229, H.232, F.233, R.236
- Chain F: W.237, R.242, F.243, L.244, Q.245, S.246, T.247
- Chain I: L.179, L.182, V.183, V.186, G.187, L.225
- Ligands: D10.6, D10.34
10 PLIP interactions:6 interactions with chain B, 3 interactions with chain F, 1 interactions with chain I- Hydrophobic interactions: B:L.142, B:F.229, B:F.229, B:F.233, F:W.237, F:W.237, I:L.182
- Salt bridges: B:H.232, B:R.236
- Hydrogen bonds: F:Q.245
P1O.38: 19 residues within 4Å:- Chain F: L.142, F.229, H.232, F.233, R.236
- Chain G: W.237, R.242, F.243, L.244, S.246, T.247
- Chain H: L.179, L.182, V.183, V.186, G.187, L.225
- Ligands: D10.32, D10.43
9 PLIP interactions:6 interactions with chain F, 1 interactions with chain H, 2 interactions with chain G- Hydrophobic interactions: F:L.142, F:F.229, F:F.229, F:F.233, H:L.182, G:W.237, G:W.237
- Salt bridges: F:H.232, F:R.236
P1O.40: 11 residues within 4Å:- Chain C: W.79, F.160, I.164
- Chain D: R.233
- Chain G: V.134, L.137, S.138, G.139, S.140, F.143
- Ligands: P1O.22
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain G- Hydrophobic interactions: C:F.160, C:F.160, G:F.143, G:F.143
P1O.56: 21 residues within 4Å:- Chain H: K.19, W.21, F.24, A.25, I.28, Y.29, T.74, L.78, Y.81, L.82, R.101, T.104, V.107, W.108, A.111, I.154, I.157, T.158, Y.165, R.169
- Ligands: PLC.55
6 PLIP interactions:6 interactions with chain H- Hydrophobic interactions: H:W.21, H:W.21, H:F.24, H:W.108
- Salt bridges: H:K.19, H:K.19
P1O.57: 18 residues within 4Å:- Chain F: S.140, L.142, F.143, I.146
- Chain G: T.247
- Chain H: S.76, W.79, G.80, W.83, F.160, F.163, I.164, K.167, I.177, L.182, V.186, F.189
- Ligands: P1O.31
6 PLIP interactions:5 interactions with chain H, 1 interactions with chain G- Hydrophobic interactions: H:W.83, H:W.83, H:F.160, H:L.182, G:T.247
- Salt bridges: H:K.167
P1O.68: 21 residues within 4Å:- Chain I: K.19, W.21, F.24, A.25, I.28, Y.29, T.74, L.78, Y.81, L.82, R.101, T.104, V.107, W.108, A.111, I.154, I.157, T.158, Y.165, R.169
- Ligands: PLC.67
6 PLIP interactions:6 interactions with chain I- Hydrophobic interactions: I:W.21, I:W.21, I:F.24, I:W.108
- Salt bridges: I:K.19, I:K.19
P1O.69: 19 residues within 4Å:- Chain B: S.140, L.142, F.143, I.146, V.147
- Chain F: T.247
- Chain I: S.76, W.79, G.80, W.83, F.160, F.163, I.164, K.167, I.177, L.182, V.186, F.189
- Ligands: P1O.5
6 PLIP interactions:5 interactions with chain I, 1 interactions with chain F- Hydrophobic interactions: I:W.83, I:W.83, I:F.160, I:L.182, F:T.247
- Salt bridges: I:K.167
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x HXG: 1,2-dihexanoyl-sn-glycero-3-phosphocholine(Non-covalent)
HXG.15: 14 residues within 4Å:- Chain A: D.82, Q.145, G.146
- Chain C: W.205, F.206, M.207, E.208, P.214, Y.217
- Ligands: PLC.14, D10.16, PLC.23, PLC.45, D10.51
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:W.205, C:W.205, C:P.214, C:Y.217
HXG.19: 10 residues within 4Å:- Chain B: I.102, F.106
- Chain C: L.34, R.37, W.38, G.41, W.114, Y.117, W.118, Y.122
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:W.118, C:Y.122, B:I.102, B:F.106
HXG.50: 13 residues within 4Å:- Chain D: Q.145, G.146
- Chain H: W.205, F.206, M.207, E.208, P.214, Y.217
- Ligands: PLC.36, PLC.45, PLC.49, D10.51, D10.63
5 PLIP interactions:5 interactions with chain H- Hydrophobic interactions: H:W.205, H:W.205, H:P.214, H:Y.217
- Hydrogen bonds: H:W.205
HXG.54: 10 residues within 4Å:- Chain G: I.102, F.106
- Chain H: L.34, R.37, W.38, G.41, W.114, Y.117, W.118, Y.122
4 PLIP interactions:2 interactions with chain H, 2 interactions with chain G- Hydrophobic interactions: H:W.118, H:Y.122, G:I.102, G:F.106
HXG.62: 13 residues within 4Å:- Chain E: Q.145, G.146
- Chain I: W.205, F.206, M.207, E.208, P.214, Y.217
- Ligands: D10.16, PLC.23, PLC.36, PLC.61, D10.63
4 PLIP interactions:4 interactions with chain I- Hydrophobic interactions: I:W.205, I:W.205, I:P.214, I:Y.217
HXG.66: 10 residues within 4Å:- Chain F: I.102, F.106
- Chain I: L.34, R.37, W.38, G.41, W.114, Y.117, W.118, Y.122
4 PLIP interactions:2 interactions with chain I, 2 interactions with chain F- Hydrophobic interactions: I:W.118, I:Y.122, F:I.102, F:F.106
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tucci, F.J. et al., Product analogue binding identifies the copper active site of particulate methane monooyxgenase. Nat Catal (2023)
- Release Date
- 2023-11-15
- Peptides
- Particulate methane monooxygenase alpha subunit: ADE
Particulate methane monooxygenase beta subunit: BFG
Ammonia monooxygenase/methane monooxygenase, subunit C family protein: CHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
EE
IB
BF
JG
FC
CH
GI
K - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 12 x CU: COPPER (II) ION(Non-covalent)
- 18 x D10: DECANE(Non-functional Binders)(Non-covalent)
- 18 x PLC: DIUNDECYL PHOSPHATIDYL CHOLINE(Non-covalent)
- 12 x P1O: 1,2-DIDECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 3 x CL: CHLORIDE ION(Non-functional Binders)
- 6 x HXG: 1,2-dihexanoyl-sn-glycero-3-phosphocholine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tucci, F.J. et al., Product analogue binding identifies the copper active site of particulate methane monooyxgenase. Nat Catal (2023)
- Release Date
- 2023-11-15
- Peptides
- Particulate methane monooxygenase alpha subunit: ADE
Particulate methane monooxygenase beta subunit: BFG
Ammonia monooxygenase/methane monooxygenase, subunit C family protein: CHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AD
EE
IB
BF
JG
FC
CH
GI
K - Membrane
-
We predict this structure to be a membrane protein.